<DOC>
	<DOCNO>NCT01785290</DOCNO>
	<brief_summary>The aim study determine effect low dosage prophylactic haloperidol patient high risk develop delirium , define expect ICU length stay &gt; 1 day . The investigator hypothesize haloperidol prophylaxis patient high risk delirium reduce 28-day mortality , delirium delirium relate outcome . Two different dosage haloperidol use study compare placebo . A dosage 1mg , 2mg placebo three time day double-blinded fashion result three-armed multicentre randomize double-blinded placebo-controlled trial . To relate potential beneficial effect haloperidol priori risk develop delirium , PREDELIRIC-model ( delirium prediction model ICU patient ) use . This enable investigator determine preventive efficacy haloperidol patient group base risk develop delirium .</brief_summary>
	<brief_title>pRophylactic halopEriDol Use Delirium iCu patiEnts With High Risk Delirium</brief_title>
	<detailed_description>In study high risk patient include . Based historical data investigator know median predict delirium risk 35 % patient expect stay ICU one day . This consider high risk develop delirium . To assess patient delirium use Confusion Assessment Method ( CAM ) -ICU part daily clinical practice participate centre . In study , high risk patient receive three time day study drug two group receive low dose haloperidol ( 1mg 2mg ) third arm receive placebo . This drug worldwide first choice drug treat delirious patient . When delirium diagnose , patient treat accord delirium protocol , use high dosage prophylactic treatment period describe study protocol . It recognize early treatment delirium beneficial effect compare delayed treatment , also evidence delirium prevention ICU patient beneficial effect , design previous study optimal . Potential side-effects haloperidol include , extrapyramidal symptom , drowsiness , agitation , ventricular arrhythmia . The latter extremely rare ( case-reports publish ) relate high dosage haloperidol . With dosage use present study relevant side-effects anticipate . Nevertheless , give preventive nature study , extra attention pay recognition possible side-effects haloperidol protocol . Importantly , three recent prophylactic haloperidol study relevant side-effects , particular ventricular arrhythmia , report use similar low dosage haloperidol describe present protocol . During study several inter-rater reliability check ( delirium expert versus ICU nurse ) concern CAM_ICU assessment perform . Also medical nursing file check secure quality delirium diagnose . The study monitor ( site ) , randomly include patient data check delirium diagnose endpoint study . All data collect Electronic CRF . A check completeness data build-in . All variable define use data dictionary ( use NICE data dictionary ) supplement definition PREDELIRIC-model predictor , delirium diagnosis ( least one positive CAM-ICU assessment ) , delirium duration . Sample size calculation base effect number day survival 28-days mortality derive evaluation study use low dosage prophylactic haloperidol . If true hazard ratio control patient relative intervention patient 0.85 , take account accrual time 90 day 28 day follow-up , investigator need study 647 patient per intervention group 647 control patient able reject null hypothesis experimental control survival curve equal probability ( power ) 0.80 . The Type I error probability associate test null hypothesis 0.05 . Taken account drop 10 % investigator include 715 patient per group ; total 2145 patient . The investigator assume effect number day survival 28-days mortality comparable two intervention group . The Cox-regression analysis group three level ( placebo , 1 mg 2 mg haloperidol three time daily ) . A Data Safety Monitoring Board ( DSMB ) monitor safety study include interim analysis safety/futility 175-350 500 patient safety superiority 1000 patient . Followed final analysis 2145 patient . Only interim analysis 500 1000 patient adjust covariates ( age , gender , delirium prediction score sepsis ) perform determine effect 28-day survival This multicenter study perform : - Radboud University Nijmegen Medical Centre - University Medical Centre Utrecht - Medical Centre Leeuwarden ( stop January 2014 ) - Onze Lieve Vrouwen Gasthuis , Amsterdam - Isala Clinic , Zwolle ( stop June 2014 ) - Canisius Wilhelmina Ziekenhuis , Nijmegen - Medisch Spectrum Twente , Enschede - Gelre Hospital , Apeldoorn - Atrium Medical Centre , Heerlen - Jeroen Bosch Hospital , Den-Bosch - Atrium Medical Centre , Heerlen - Medical Centre Haaglanden ( Westeinde Antoniushove ) , Den-Haag - Bronovo Hospital , Den-Haag - St. Jansdal Hospital , Harderwijk - Maxima Medical Centre , Veldhoven - University Medical Centre , Groningen - Amphia Hospital , Breda - VieCuri Hospital , Venlo - Scheper Hospital , Emmen - Diakonessenhuis Hospital , Utrecht - Haga Hospital , Den-Haag</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>age ≥ 18 expect length ICU stay one day history epilepsy , Parkinson 's disease , hypokinetic rigid syndrome , dementia alcohol withdrawal syndrome patient admit ICU neurological reason ( include postresuscitation patient ) patient treat antipsychotic prolong QTctime ( &gt; 500msec ) history serious ventricular arrhythmia ( last 12 month ) pregnancy/breast feed delirious ICU admission serious auditory visual disorder ICUstay ≤1 day unable understand Dutch severely mentally disabled serious receptive aphasia moribund expect survive 2 day know allergy haloperidol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Delirium</keyword>
	<keyword>Survival</keyword>
	<keyword>Side-effects</keyword>
	<keyword>QoL</keyword>
</DOC>